Monopar Therapeutics Inc. Common Stock (MNPR)

Health Care·equity

$78.96

-5.98% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

31/ 100

Score level

Below average

6 of 6 checks had data

Business numbers score is on the low side, with smart-money score is on the low side.

MNPR scores higher than 34% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Monopar Therapeutics Inc. Common Stock (MNPR) scores 31 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.88× 30-day average
52-week range: 50.07 – 124.82
Market cap: $647.52M
Earnings date: 11 Nov 2026

Volume: 135,845
Avg. volume (30d): 153,843

Open: 83.47
Previous close: 83.98
Day's range (regular session): 78.80 – 84.04

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 1.54
P/E (TTM): —
EPS (TTM): -2.17

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for MNPR

31 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for MNPR. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about MNPR right now

Monopar Therapeutics Inc. Common Stock (MNPR) currently scores 31/100 on the Market Census six-factor composite, at the Below average score level. MNPR is -5.98% on the day and +2.28% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of MNPR's data reads poorly than well. The level is a "look before you act" flag. It is not advice. MNPR's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about MNPR itself. The weakest factor is company finances at 7/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See MNPR in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score